2,100
Participants
Start Date
March 26, 2019
Primary Completion Date
March 26, 2029
Study Completion Date
March 26, 2029
3 week RT
40 Gy in 15 fractions over 3 weeks to the whole breast or chest wall. Patients undergoing breast conservation therapy will receive additional boost radiotherapy to the tumor bed. The supraclavicular fossa will be treated in patient with node positive disease or those receiving neoadjuvant chemotherapy. IMC and Axillary radiotherapy will be given as per the institutional policy. Boost Dose schedule for BCS patients will be 8 Gy delivered in 15 fractions simultaneously with tangential EBRT. In institutions planning for sequential boost, a dose of 12 Gy in 4 fractions will be delivered after whole breast EBRT.
1 week RT
26 Gy in 5 fractions over 1 week to the whole breast or chest wall. Treatment volumes will be same as the control arm. Additional boost will be delivered to patients who have undergone breast conservation. Boost Dose schedule for BCS patients will be 6 Gy delivered in 5 fractions simultaneously with tangential EBRT. In institutions planning for sequential boost, a dose of 12 Gy in 4 fractions will be delivered after whole breast EBRT.
RECRUITING
Sanjoy Chatterjee, Kolkata
Collaborators (1)
Christian Medical College, Vellore, India
OTHER
Sanjay Gandhi Postgraduate Institute of Medical Sciences
OTHER_GOV
Kasturba Medical College
OTHER
Tata Medical Center
OTHER